Everolimus delayed and suppressed cytomegalovirus DNA synthesis, spread of the infection, and alleviated cytomegalovirus infection

Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients

Raimund Margreiter, Willem Weimar, Jacques Dantal et al. · American Journal of Transplantation · 2005 · 218 citations

Medicine, Nephrology, Pharmacology +17

Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses

Cláudia Rosso Felipe, Alexandra Ferreira, Marina Pontello Cristelli et al. · American Journal of Transplantation · 2015 · 157 citations · Full text

Medicine, Infectious Diseases, Nephrology +17

Human Cytomegalovirus Infection Induces Rapamycin-Insensitive Phosphorylation of Downstream Effectors of mTOR Kinase

Sagar B. Kudchodkar, Yongjun Yu, Tobi G. Maguire et al. · Journal of Virology · 2004 · 156 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

Cytomegalovirus Incidence Between Everolimus Versus Mycophenolate in De Novo Renal Transplants: Pooled Analysis of Three Clinical Trials

Daniel C. Brennan, Christophe Legendre, Dharmesh Patel et al. · American Journal of Transplantation · 2011 · 155 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial

Bert Andersson, Finn Gustafsson, Hans Eiskjær et al. · American Journal of Transplantation · 2014 · 151 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17